Direct and Indirect Economic Burden of Chronic Liver Disease in the United States

Clinical Gastroenterology and Hepatology

Volumn 15, Issue 5, 2017, Pages 759-766.e5

  Stepanova, Maria ^a,b   De Avila, Leyla ^a   Afendy, Mariam ^a,c   Younossi, Issah ^a,c   Pham, Huong ^a,c   Cable, Rebecca ^a,c   Younossi, Zobair M ^a,c  

^a BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^b Center for Outcomes Research in Liver Diseases   (United States)

^c INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

Cirrhosis; Costs; HRQOL; NAFLD; Population

Indexed keywords

ADL DISABILITY; ADULT; ARTICLE; CHRONIC LIVER DISEASE; COMORBIDITY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; DISTRESS SYNDROME; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH STATUS; HEPATITIS C; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENTAL HEALTH; PRODUCTIVITY; QUALITY OF LIFE; SELF REPORT; UNEMPLOYMENT; UNITED STATES; VIRUS HEPATITIS; WORK DISABILITY; ADOLESCENT; AGED; CHRONIC DISEASE; ECONOMICS; LIVER DISEASE; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; EFFICIENCY; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; QUALITY OF LIFE; UNITED STATES; YOUNG ADULT;

EID: 84991234127     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2016.07.020     Document Type: Article

References (38)

1. 1 Heidelbaugh, J.J., Bruderly, M., Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. Am Fam Physician 74 (2006), 756–762.
2. 2 Mokdad, A.A., Lopez, A.D., Shahraz, S., et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med, 12, 2014, 145.
3. 3 Blachier, M., Leleu, H., Peck-Radosavljevic, M., et al. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 58 (2013), 593–608.
4. 4 Younossi, Z.M., Stepanova, M., Afendy, M., et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 9 (2011), 524–530.e1.
5. 5 Canadian Liver Foundation. Available from: http://www.liver.ca/liver-disease/. Accessed: March 23, 2016.
6. 6 Stepanova, M., Wai, H., Saab, S., et al. The portrait of an adult liver transplant recipient in the United States from 1987 to 2013. JAMA Intern Med 174 (2014), 1407–1409.
7. 7 Xu, J., Murphy, S.L., Kochanek, K.D., et al. Deaths: final data for 2013. Natl Vital Stat Rep 62 (2016), 1–119.
8. 8 Ryerson, A.B., Eheman, C.R., Altekruse, S.F., et al. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer 122 (2016), 1312–1337.
9. 9 Foster, G.R., Goldin, R.D., Thomas, H.C., Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 27 (1998), 209–212.
10. 10 Cordoba, J., Flavia, M., Jacas, C., et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 39 (2003), 231–238.
11. 11 Hauser, W., Holtmann, G., Grandt, D., Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenterol Hepatol 2 (2004), 157–163.
12. 12 David, K., Kowdley, K.V., Unalp, A., et al. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology 49 (2009), 1904–1912.
13. 13 Afendy, A., Kallman, J.B., Stepanova, M., et al. Predictors of health-related quality of life in patients with chronic liver disease. Aliment Pharmacol Ther 30 (2009), 469–476.
14. 14 Younossi, Z.M., Jiang, Y., Smith, N.J., et al. Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: insights from a work productivity economic model from the United States. Hepatology 61 (2015), 1471–1478.
15. 15 Younossi, Z., Brown, A., Buti, M., et al. Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries. J Viral Hepat 23 (2016), 217–226.
16. 16 Aberg, F., Rissanen, A.M., Sintonen, H., et al. Health-related quality of life and employment status of liver transplant patients. Liver Transpl 15 (2009), 64–72.
17. 17 Younossi, Z.M., Stepanova, M., Henry, L., et al. Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C virus. J Viral Hepat 23 (2016), 623–630.
18. 18 Neff, G.W., Duncan, C.W., Schiff, E.R., The current economic burden of cirrhosis. Gastroenterol Hepatol (N Y) 7 (2011), 661–671.
19. 19 The Bureau of Labor Statistics. CPI Detailed Report: Data for December 2014. Available from: http://www.bls.gov/cpi/cpid1412.pdf. Accessed: March 23, 2016.
20. 20 Razavi, H., Elkhoury, A.C., Elbasha, E., et al. Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology 57 (2013), 2164–2170.
21. 21 Agency for Healthcare Research and Quality. Documentation for MEPS HC-163 2013 Full Year Consolidated Data File. Available from: http://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h163/h163doc.pdf. Accessed: March 23, 2016.
22. 22 Ware, J. Jr., Kosinski, M., Keller, S.D., A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34 (1996), 220–233.
23. 23 Kessler, R.C., Andrews, G., Colpe, L.J., et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med 32 (2002), 959–976.
24. 24 Kroenke, K., Spitzer, R.L., Williams, J.B., The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 41 (2003), 1284–1292.
25. 25 Brazier, J.E., Roberts, J., The estimation of a preference-based measure of health from the SF-12. Med Care 42 (2004), 851–859.
26. 26 McLernon, D.J., Dillon, J., Donnan, P.T., Health-state utilities in liver disease: a systematic review. Med Decis Making 28 (2008), 582–592.
27. 27 Ong, S.C., Mak, B., Aung, M.O., et al. Health-related quality of life in chronic hepatitis B patients. Hepatology 47 (2008), 1108–1117.
28. 28 Levy, A.R., Kowdley, K.V., Iloeje, U., et al. The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons. Value Health 11 (2008), 527–538.
29. 29 Sarpel, D., Baichoo, E., Dieterich, D.T., Chronic hepatitis B and C infection in the United States: a review of current guidelines, disease burden and cost effectiveness of screening. Expert Rev Anti Infect Ther 14 (2016), 511–521.
30. 30 El Khoury, A.C., Vietri, J., Prajapati, G., The burden of untreated hepatitis C virus infection: a US patients' perspective. Dig Dis Sci 57 (2012), 2995–3003.
31. 31 Younossi, Z., Henry, L., Systematic review: patient-reported outcomes in chronic hepatitis C–the impact of liver disease and new treatment regimens. Aliment Pharmacol Ther 41 (2015), 497–520.
32. 32 Teshale, E.H., Xing, J., Moorman, A., et al. Higher all-cause hospitalization among patients with chronic hepatitis C: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2013. J Viral Hepat 23 (2016), 748–754.
33. 33 Gordon, S.C., Pockros, P.J., Terrault, N.A., et al. Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection. Hepatology 56 (2012), 1651–1660.
34. 34 Golabi, P., Otgonsuren, M., Cable, R., et al. Non-alcoholic fatty liver disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL). Health Qual Life Outcomes, 14, 2016, 18.
35. 35 Younossi, Z.M., Henry, L., Economic and quality-of-life implications of non-alcoholic fatty liver disease. Pharmacoeconomics 33 (2015), 1245–1253.
36. 36 McAdam-Marx, C., McGarry, L.J., Hane, C.A., et al. All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective. J Manag Care Pharm 17 (2011), 531–546.
37. 37 Petta, S., Maida, M., Macaluso, F.S., et al. Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies. Gastroenterology 150 (2016), 145–155.e4.
38. 38 Younossi, Z., Park, H., Henry, L., et al. Extra-hepatic manifestations of hepatitis C-a meta-analysis of prevalence, quality of life, and economic burden. Gastroenterology 150 (2016), 1599–1608.